Breakdown | ||||
Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 | Jun 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
0.00 | 0.00 | 26.82K | 509.17K | 107.30K | Gross Profit |
0.00 | 0.00 | 26.24K | 509.10K | 107.04K | EBIT |
-1.09M | 4.77M | -762.11K | -3.10M | -2.49M | EBITDA |
418.95K | 4.77M | -892.36K | -3.10M | -2.48M | Net Income Common Stockholders |
418.95K | 4.77M | -762.11K | -7.70M | -2.54M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
129.31K | 50.24K | 5.00 | 50.93K | 180.40K | Total Assets |
139.34K | 50.24K | 6.00 | 154.06K | 360.72K | Total Debt |
2.65M | 1.94M | 2.42M | 2.42M | 1.74M | Net Debt |
2.52M | 1.89M | 2.41M | 2.36M | 1.56M | Total Liabilities |
2.86M | 3.69M | 8.94M | 8.33M | 3.47M | Stockholders Equity |
-2.72M | -3.64M | -8.94M | -8.18M | -3.11M |
Cash Flow | Free Cash Flow | |||
-802.71K | -919.76K | -50.92K | 1.15M | -1.64M | Operating Cash Flow |
-802.71K | -919.76K | -50.92K | 1.15M | -1.60M | Investing Cash Flow |
0.00 | 0.00 | 0.00 | 0.00 | -39.60K | Financing Cash Flow |
881.78K | 970.00K | 0.00 | -1.28M | 1.81M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
73 Outperform | £6.36B | 11.72 | 15.82% | 6.68% | -0.70% | 388.07% | |
59 Neutral | $13.76B | 7.65 | -2.18% | 3.85% | 2.32% | -36.56% | |
53 Neutral | £73.34M | 4.58 | 21.85% | ― | -6.57% | ― | |
48 Neutral | £164.95M | 99.88 | -42.53% | ― | -16.14% | -5856.63% | |
36 Underperform | £585.98K | 1.33 | -15.41% | ― | ― | 58.23% |
Iconic Labs PLC, listed on the London Stock Exchange under the ticker ICON, has announced the scheduling of its Annual General Meeting (AGM) for May 15, 2025, at the offices of RWK Goodman in London. The company has made the Notice of AGM available on its website and has sent proxy forms to its shareholders, indicating its commitment to maintaining transparency and shareholder engagement.
Spark’s Take on GB:ICON Stock
According to Spark, TipRanks’ AI Analyst, GB:ICON is a Underperform.
Iconic Labs plc is in a challenging financial position, with the income statement, balance sheet, and cash flow all indicating distress. The technical analysis offers little positive momentum, and recent corporate events add to the uncertainty surrounding the company’s future. Despite a low P/E ratio suggesting potential undervaluation, the overall risk profile remains high due to substantial financial and operational uncertainties.
To see Spark’s full report on GB:ICON stock, click here.
Iconic Labs PLC announced its interim unaudited financial results for the six months ending December 31, 2024, revealing a loss of £293,680. The company had been focused on acquiring ITS Holdings 2023 Ltd, but the deal was not completed. Iconic Labs is now seeking alternative acquisition targets while reducing costs. The company faces significant financial uncertainty, relying on short-term funding from an investor, and may need to wind down operations if a suitable target is not found. The company’s shares are expected to be re-admitted to trading in early April 2025.
Iconic Labs PLC has published revised audited financial results for the year ended 30 June 2024, updating its annual report and accounts to reflect changes in trade creditors and share capital. The company has also terminated the proposed acquisition of In The Style Fashion Limited and is actively seeking alternative acquisition targets to ensure long-term growth and value for shareholders. The company’s financial stability is contingent on finding a suitable target, as its sole asset, Gay Star News, is not cash-generative, and it relies on a financing facility with specific conditions. Failure to meet these conditions could lead to significant financial risks, including potential administration.
Iconic Labs PLC announced the termination of its potential acquisition of ITS Holdings 2023 Ltd, which owns In the Style Fashion Ltd, an online fashion retailer. The transaction would have been considered a reverse takeover under UK Listing Rules, but will not proceed, prompting Iconic Labs to explore alternative transactions. The company is also seeking to restore its listing on the London Stock Exchange, with further announcements expected.
Iconic Labs PLC has announced an update regarding the holdings of ABO Infinium Americas OpCo LTD in the company. This notification brings ABO’s current stake to 3.08% of the total voting rights in Iconic Labs. This update is vital for stakeholders as it signifies a change in the distribution of voting rights within the company, potentially impacting strategic decisions and company governance.